CC BY-NC 4.0 · Arch Plast Surg 2018; 45(06): 593-597
DOI: 10.5999/aps.2017.00122
Case Report

Complex sternal and rib reconstruction with allogeneic material

Department of Surgery, University of Oklahoma College of Medicine-Tulsa, Tulsa, OK, USA
,
Robert Lloyd Archer
Saint Francis Heart Hospital, Tulsa, OK, USA
,
Sharon Kaye Tarpley
Tulsa Plastic Surgery, Tulsa, OK, USA
,
Archibald Sanford Miller III
Tulsa Plastic Surgery, Tulsa, OK, USA
› Author Affiliations

Sternal malunion, or loss, developed after a median sternotomy cannot only be difficult to manage and treat, but also may diminish one’s quality-of-life drastically. The technique presented here represents a multispecialty approach in one stage for the reconstruction of an unstable thoracic cage. The procedure utilized a donated sternum and ribs. The sternum with ribs harvested from a single donor included adipose derived stromal vascular fraction (ADSVF) cells with marrow also from the same donor. Autologous muscle flaps, stabilized with acellular dermal matrix were utilized to provide a robust blood supply to the ADSVF cells and bone grafts. Acellular dermal matrix was used to construct the ribs and stabilize the plugs of stem cells and bone. These procedures, in the hands of multispecialty physicians, have led to several successful reconstructions involving complex chest wall deformities. This surgical intervention was performed in a one stage operation. This represents the first successful complete sternal transplant in a patient with return to normal activities and increased quality-of-life.



Publication History

Received: 31 January 2017

Accepted: 07 September 2018

Article published online:
03 April 2022

© 2018. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • REFERENCES

  • 1 Mansour KA, Thourani VH, Losken A. et al. Chest wall resections and reconstruction: a 25-year experience. Ann Thorac Surg 2002; 73: 1720-5
  • 2 Chepla KJ, Salgado CJ, Tang CJ. et al. Late complications of chest wall reconstruction: management of painful sternal nonunion. Semin Plast Surg 2011; 25: 98-106
  • 3 Pancholy B, Raman J. Chest wall reconstruction using sternal plating in patients with complex sternal dehiscence. Ann Thorac Surg 2015; 99: 2228-30
  • 4 Kalab M, Molitor M, Kubesova B. et al. Use of allogenous bone graft and osteosynthetic stabilization in treatment of massive post-sternotomy defects. Eur J Cardiothorac Surg 2012; 41: e182-4
  • 5 Banyard DA, Salibian AA, Widgerow AD. et al. Implications for human adipose-derived stem cells in plastic surgery. J Cell Mol Med 2015; 19: 21-30
  • 6 Bersenev A. Breaking down fat: ISCT, and IFATS position statements on stromal cells from adipose tissue [Internet]. Stem Cell Assays. 2013 [cited 2018 Sep 27]. Available from http://stemcellassays.com/2013/04/breaking-fat-isct-ifats-position-statement/
  • 7 Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-84
  • 8 Losken A, Thourani VH, Carlson GW. et al. A reconstructive algorithm for plastic surgery following extensive chest wall resection. Br J Plast Surg 2004; 57: 295-302
  • 9 Bryant JR, Eid R, Spann JC. et al. Chest wall reconstruction with creation of neoribs using mesenchymal cell bone allograft and porcine small intestinal submucosa. Plast Reconstr Surg 2010; 126: 148e-149e
  • 10 Wakitani S, Okabe T, Horibe S. et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 2011; 5: 146-50
  • 11 Torsvik A, Bjerkvig R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev 2013; 39: 180-8